These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15199855)

  • 1. An updated guide to genotype interpretation.
    MacArthur RD
    AIDS Read; 2004 May; 14(5):256-8, 261-4, 266. PubMed ID: 15199855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
    Vercauteren J; Vandamme AM
    Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.
    Schmidt B; Walter H; Zeitler N; Korn K
    AIDS Rev; 2002; 4(3):148-56. PubMed ID: 12416449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 antiretroviral resistance testing laboratories.
    Hofherr LK; Francis DP; Astles JR; Schalla WO
    Clin Lab Sci; 2002; 15(4):213-9. PubMed ID: 12776781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
    J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 genotypic drug-resistance interpretation algorithms need to include hypersusceptibility-associated mutations.
    Wang K; Samudrala R; Mittler JE
    J Infect Dis; 2004 Dec; 190(11):2055-6; author reply 2056. PubMed ID: 15529272
    [No Abstract]   [Full Text] [Related]  

  • 7. Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.
    Dianzani F; Frascione E
    Scand J Infect Dis Suppl; 2003; 106():108-9. PubMed ID: 15000599
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral drug resistance testing.
    Sen S; Tripathy SP; Paranjape RS
    J Postgrad Med; 2006; 52(3):187-93. PubMed ID: 16855319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of different systems for interpreting results of genotypic antiretroviral drug resistance tests.
    García F; Palomares JC; Martínez NM; Alvarez M; Suarez S; García F; Rodríguez JM; Quero JH; del Carmen Maroto M
    Antivir Ther; 2003 Jun; 8(3):251-2. PubMed ID: 12924543
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.
    Wilson JW
    AIDS Read; 2003 Jan; 13(1):25-30, 35-8. PubMed ID: 12569892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
    Vandamme AM; Camacho RJ; Ceccherini-Silberstein F; de Luca A; Palmisano L; Paraskevis D; Paredes R; Poljak M; Schmit JC; Soriano V; Walter H; Sönnerborg A;
    AIDS Rev; 2011; 13(2):77-108. PubMed ID: 21587341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution.
    Johnson JA; Geretti AM
    J Antimicrob Chemother; 2010 Jul; 65(7):1322-6. PubMed ID: 20466851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand.
    Poonpiriya V; Sungkanuparph S; Leechanachai P; Pasomsub E; Watitpun C; Chunhakan S; Chantratita W
    J Virol Methods; 2008 Jul; 151(1):79-86. PubMed ID: 18462814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.
    de Mendoza C; Anta L; García F; Pérez-Elías MJ; Gutiérrez F; Llibre JM; Menéndez-Arias L; Dalmau D; Soriano V
    AIDS Rev; 2009; 11(1):39-51. PubMed ID: 19290033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
    Zolopa AR
    J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.